Skip to main content

Peer Review reports

From: Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safety

Original Submission
20 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Aug 2022 Reviewed Reviewer Report
8 Sep 2022 Reviewed Reviewer Report
24 Sep 2022 Author responded Author comments - Thin Thin Win
Resubmission - Version 3
24 Sep 2022 Submitted Manuscript version 3
27 Sep 2022 Author responded Author comments - Thin Thin Win
Resubmission - Version 4
27 Sep 2022 Submitted Manuscript version 4
3 Oct 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
17 Oct 2022 Editorially accepted
5 Nov 2022 Article published 10.1186/s12885-022-10225-y

You can find further information about peer review here.

Back to article page